Higher hemoglobin target with epoetin alfa is hrmful in chronic kidney disease

被引：0

|

作者：

Singh, A. K.

Szczech, L.

Tang, K. L.

机构：

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2007年 / 74卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：148 / 148

页数：1

相关论文

共 50 条

[41] Cost-effectiveness of epoetin alfa in patients on chronic kidney dialysis
Hollenbeak, Christopher
Davies, Andrew
McClellan, William M.
de Lissovoy, Gregory
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A45 - A45
[42] Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?
Wyatt, Christina M.
Drueke, Tilman B.
KIDNEY INTERNATIONAL, 2016, 89 (05) : 971 - 973
[43] The Evolution of Target Hemoglobin Levels in Anemia of Chronic Kidney Disease
Bazeley, Jonathan
Wish, Jay B.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 229 - 236
[44] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease Centre A Retrospective Cohort Study
Gobin, Jaya
Cernii, Aura
McLean, Rosella
Finkelstein, Fredric O.
Simon, David B.
CLINICAL DRUG INVESTIGATION, 2011, 31 (02) : 113 - 120
[45] Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis - Author's reply
Scott, SD
PHARMACOTHERAPY, 2003, 23 (05): : 693 - 694
[46] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
Lafeuille, M. H.
Bailey, R. A.
Senbetta, M.
McKenzie, R. S.
Lefebvre, P.
VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
[47] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN A CHRONIC KIDNEY DISEASE POPULATION TREATED IN THE HOSPITAL OUTPATIENT SETTING
Vekeman, Francis
McKenzie, R. Scott
Lafeuille, Marie-Helene
Bailey, Robert A.
Piech, Catherine Tak
Lefebvre, Patrick
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A78 - A78
[48] COST EFECTIVNESS OF DARBEPOETIN ALFA VERSUS EPOETIN ALFA IN THE MANAGEMENT OF ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE:HEALTH INSURANCE PERSPECTIVE
Fouad, S.
VALUE IN HEALTH, 2016, 19 (07) : A589 - A589
[49] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease CentreA Retrospective Cohort Study
Jaya Gobin
Aura Cernii
Rosella McLean
Fredric O. Finkelstein
David B. Simon
Clinical Drug Investigation, 2011, 31 : 113 - 120
[50] Epoetin alfa and darbepoetin alfa dosing trends and drug costs in elderly pre-dialysis chronic kidney disease patients
Mody, S.
Padmanabhan, V
Bookhart, B.
Mckenzie, R. S.
VALUE IN HEALTH, 2007, 10 (03) : A12 - A13

← 1 2 3 4 5 →